Strategic Evolution of Zhifei Biological Products in the Post-Pandemic Era: A Financial and Operational Analysis
DOI:
https://doi.org/10.54097/jbm2pt29Keywords:
Zhifei Biological Products, Post-pandemic growth, Vaccine development, Strategic analysis, pharmaceutical innovation.Abstract
In the evolving landscape of the pharmaceutical industry post-COVID-19, Zhifei Biological Products stands out for its strategic maneuvering and financial growth. This paper investigates Zhifei Biological Products' financial resilience and strategic initiatives, emphasizing its focus on vaccine development and metabolic disease treatments. Through financial report analysis, the study reveals Zhifei's significant expansion in key sectors including mRNA and RSV vaccines, alongside its strategic partnerships for Shingles and HPV vaccines. The company's adaptability in navigating market challenges, leveraging R&D investments, and strategic collaborations underlines its potential for sustained growth. The analysis sheds light on Zhifei's approach to diversifying its portfolio and enhancing its market position through innovation in vaccine technology. The findings highlight the importance of strategic flexibility and innovation in securing competitive advantage and driving growth in the post-pandemic era, offering valuable insights for stakeholders in the pharmaceutical industry.
Downloads
References
Voronkova, O. Y., Volokhova, T. V., Lebedeva, E. S., Smirnova, A. V., & Tubalets, A. A. (2022). Priorities for the Development of Medicinal Plant Growing in a Post-Pandemic Environment. Siberian Journal of Life Sciences and Agriculture, 14 (1), 436 - 451.
Nakashima, A., Kodama, K., & Sengoku, S. (2023). Strategic trends of pharmaceutical companies: A growth model through regional focus and inter-regional alliances. Drug Discovery Today, 28 (7).
Rathi, S., Majumdar, A., & Chatterjee, C. (2024). Did the COVID-19 pandemic propel usage of AI in pharmaceutical innovation? New evidence from patenting data. Technological Forecasting and Social Change, 198, 122940.
Cano-Marin, E., Ribeiro-Soriano, D., Mardani, A., & Blanco Gonzalez-Tejero, C. (2023). Exploring the challenges of the COVID-19 vaccine supply chain using social media analytics: A global perspective. Sustainable Technology and Entrepreneurship, 2, 100047.
Pessot, E., & Albini, T. (2023). COVID-19 Pandemic Impacts and Long-Term Supply Strategies of Pharmaceutical Manufacturers. In Borgianni, Y., Matt, D.T., Molinaro, M., & Orzes, G. (Eds.), Towards a Smart, Resilient, and Sustainable Industry. ISIEA 2023. Lecture Notes in Networks and Systems, vol 745. Springer, Cham.
Salem, M., Kirkham, R., Al-Sabah, R., & Chebli, S. (2023). COVID-19 and the construction sector: Impacts and an agenda for post-pandemic policy in the context of Kuwait. Journal of Engineering Research.
Wang, B. G. (2023). Zhifei Biological Products: Strategic cooperation with GSK and exclusive agency of shingles vaccine. Stock Market Dynamics Analysis, (21), 35 - 35.
Lou, S., & Yang, H. (2021). Zhifei Biological Products: Driven by both self-research and agency, a promising future.
Sun, Y. (2019). Dependency on agency: How far can Zhifei Biological Products fly? Talents, (11), 2.
Liu, C. R. (2022). The rise and challenges of Zhifei Biological Products in the vaccine market. Talents, (6), 66 - 68.
Zhao, Y. (2019). Financial statement analysis of Zhifei Biological Products based on the Harvard Analysis Framework (Doctoral dissertation, Jilin University).
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Journal of Education, Humanities and Social Sciences
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
